Sunday, 28 June 2026
AI in mammography screening, Chemotherapy drug shortages in India, Misinformation as a health risk
- 01
MASAI trial suggests AI can enhance mammography screening
The MASAI trial concludes that AI-supported mammography screening can efficiently improve screening performance and may be considered for implementation in clinical practice. However, the trial's recommendations are based on intermediate performance endpoints, and there are concerns regarding potential overdiagnosis. This finding could influence clinical practice and guidelines in Australia.
via The Lancet · also covered by The Lancet, The Lancet, The Lancet
- 02
India Faces Chemotherapy Drug Shortage Amid Conflict
The ongoing conflict in Iran has disrupted supplies of cisplatin and carboplatin in India, resulting in treatment interruptions for patients requiring chemotherapy. This shortage raises concerns about medicine access and the potential impact on patient care. The situation highlights the broader implications of geopolitical conflicts on healthcare systems.
via The Lancet
- 03
Misinformation Identified as Major Global Health Risk
The UN and the World Economic Forum have ranked misinformation and disinformation as significant global risks, surpassing threats from extreme weather and armed conflict. This issue, exacerbated by the COVID-19 pandemic, has roots that predate the crisis and continues to evolve. The rapid spread of misinformation via social media and advancements in artificial intelligence complicate the landscape, posing risks to health outcomes and undermining trust in science.
via The Lancet
- 04
Rising Cancer Incidence Among Young Adults Raises Concerns
US Senator Edward Markey highlighted the increasing incidence of cancer among young adults, describing it as a growing crisis. On June 15, he and other lawmakers urged the US National Institutes of Health to develop a national strategy to tackle this issue. Despite cancer being predominantly a disease of older individuals, there is a notable rise in early-onset cancers that warrants attention from health communities globally.
via The Lancet
- 05
High Prevalence of Mental Health Disorders in Conflict Areas
Mental health conditions are prevalent in conflict-affected settings, with the WHO estimating that around 22% of individuals in these areas suffer from a mental health disorder. This rate surpasses global averages and is attributed to prolonged exposure to trauma and instability. The findings underscore the significant psychological impact of ongoing conflict on affected populations.
via The Lancet
- 06
The Complexity of Learning from Experience in Healthcare
The Lancet discusses the subjective nature of experience and its impact on learning within healthcare. It highlights how individuals may have differing accounts of the same event, which can evolve over time and overshadow objective facts. The article emphasises the challenges of synthesising diverse perspectives and interpretations into a coherent understanding. This complexity is particularly relevant for clinicians as they navigate patient experiences and clinical outcomes.
via The Lancet
MDDR is a news digest for medical professionals. It is not medical advice and should not be relied on for clinical decision-making.